Oxidative stress assays are widely used to determine the levels of oxidative stress markers in cultured cells used in research and bioproduction. The growth of the oxidative stress assays market is mainly driven by rapid growth in the biopharmaceutical industry, strong trend of R&D investments in pharmaceutical and biotechnology industries, technological advancements like high-content screening for drug discovery, and government funding for life science research. The high growth potential in emerging markets provides new growth opportunities to players in the oxidative stress assays market.
In this report, the oxidative stress assays market is segmented by product, test type, technology, end user, and region. The product segments included in this report are consumables, instruments, and services. The test type segments included in this report are indirect assays, antioxidant capacity assays, enzyme-based assays, and reactive oxygen species (ROS)-based assays. The technology segments included in this report are enzyme-linked immunosorbent assay (ELISA), chromatography, flow cytometry, microscopy, high-content screening, and label-free detection technology. The end-user segments included in this report are pharmaceutical and biotechnology companies, academic research institutes, clinical laboratories, and contract research organizations (CROs). The regional segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global oxidative stress assays market and its subsegments. Secondary information was used to identify the overall revenue, geographic reach, and product portfolios of market players. Estimates of the oxidative stress assays market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
The report provides qualitative insights on the key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each segment and identifies segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the oxidative stress assays market. The company profiles include the financial performances, product portfolios, and developments of each company; whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as acquisitions; agreements, collaborations, and partnerships; new product launches; and other developments.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following: - Product Development/Innovation: Product portfolios of the top players in the oxidative stress assays market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the oxidative stress assays market - Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the oxidative stress assays market - Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various oxidative stress assays across geographies - Market Diversification: Exhaustive information about new products, recent developments, and investments in the oxidative stress assays market
Our reports have been used by over 10K customers, including:
Readers of one of the analyst’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021.The analyst has conducted similar studies among the same targeted respondents since 2012.
Where applicable, the study presents year-over-year...
The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across...
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report. The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
The chromatography resin market size is estimated to be USD 2.2 billion in 2020 and is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% between 2020 and 2025. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will...
703 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Mar 2021
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source. According to the analysis,...
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition,...
India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User (Pharmaceutical/Biotechnology Companies, CRO) By Technology (Cell Acquisition; Cell Production; Cryopreservation; Expansion & Subculture), By Region, Competition...
Regenerative Medicine
Pharmaceutical
Drug Development
Biotechnology
India
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.